IKENA ONCOLOGY INC (IKNA) Institutional Ownership
None of the superinvestors we track currently report IKENA ONCOLOGY INC (IKNA) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in IKENA ONCOLOGY INC (IKNA), this page will show smart money ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $413,867 | 308,856 |
| Q1 2025 | 1 | $376,943 | 294,487 |
| Q4 2024 | 1 | $541,528 | 330,200 |
| Q3 2024 | 1 | $693,038 | 400,600 |
| Q2 2024 | 1 | $786,060 | 476,400 |
| Q1 2024 | 1 | $1,103 | 776,600 |
| Q3 2023 | 1 | $57 | 13,094 |
| Q2 2023 | 1 | $92 | 14,094 |
Related IKNA Institutional Insights:
- IKNA Institutional Ownership & Insiders Activity
- IKNA Institutional Ownership & 13F Activity
- IKNA Top Institutional Shareholders
- IKNA Institutional Buying Activity
- IKNA Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- IKNA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings